volving echnology ntramyocardial delivery of CD 133 bone marrow cells and oronary artery bypass grafting for chronic ischemic heart isease : Safety and efficacy studies

@inproceedings{Stamm2007volvingEN,
  title={volving echnology ntramyocardial delivery of CD 133 bone marrow cells and oronary artery bypass grafting for chronic ischemic heart isease : Safety and efficacy studies},
  author={H. Stamm and H. -D. Kleine and Y Choi and Simone Dunkelmann and Jan-Arne Lauffs and Joern Lorenzen and Arp{\'a}d D{\'a}vid and Andreas Liebold and Christoph Nienaber and David Zurakowski and A Freund and Gustav Steinhoff},
  year={2007}
}
i doi:10.1016/j.jtcvs.2006.08.077 bjectives: Cell therapy may offer novel therapeutic options for chronic ischemic eart disease. In a clinical trial, we first assessed the feasibility and safety of ntramyocardial CD133 bone marrow cell injection together with coronary artery ypass grafting (CABG). We then tested the hypothesis that CABG plus CD133 ell injection would result in better contractile function than CABG alone.